Literature DB >> 3435692

Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

E Chan1, L Aarons, M Serlin, A Breckenridge, M Rowland.   

Abstract

1. The effect of subtherapeutic doses of warfarin on the activities of the four vitamin K-dependent clotting factors was studied at steady state in five patients each of whom had completed a therapeutic course of anticoagulation. 2. The four clotting factor activities were shown to be depressed to a similar extent for a given dose of warfarin. 3. The prothrombin complex activity was significantly lower than that of any of the clotting factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435692      PMCID: PMC1386334          DOI: 10.1111/j.1365-2125.1987.tb03221.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.

Authors:  F KAZMIER; J A SPITTELL; J J THOMPSON; C A OWEN
Journal:  Arch Intern Med       Date:  1965-06

2.  Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A.

Authors:  P F HJORT; O EGEBERG; S MIKKELSEN
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

3.  A study of a case of congenital hypoprothrombinaemia.

Authors:  C F BORCHGREVINK; O EGEBERG; J G POOL; T SKULASON; H STORMORKEN; B WAALER
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

Review 4.  Interindividual differences in the response to oral anticoagulants.

Authors:  A M Breckenridge
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

5.  GLC determination of warfarin in human plasma.

Authors:  D G Kaiser; R S Martin
Journal:  J Pharm Sci       Date:  1974-10       Impact factor: 3.534

Review 6.  Kinetics of pharmacologic response.

Authors:  N H Holford; L B Sheiner
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

7.  Interaction between diflunisal and warfarin.

Authors:  M J Serlin; S Mossman; R G Sibeon; K F Tempero; A M Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

Review 8.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

9.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

Review 10.  Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid.

Authors:  J W Suttie
Journal:  CRC Crit Rev Biochem       Date:  1980
View more
  5 in total

1.  Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.

Authors:  B Vadher; D L Patterson; M Leaning
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Assessment of toxicity and potential risk of the anticoagulant rodenticide diphacinone using Eastern screech-owls (Megascops asio).

Authors:  Barnett A Rattner; Katherine E Horak; Rebecca S Lazarus; Karen M Eisenreich; Carol U Meteyer; Steven F Volker; Christopher M Campton; John D Eisemann; John J Johnston
Journal:  Ecotoxicology       Date:  2012-01-08       Impact factor: 2.823

4.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

5.  A factor VII-based method for the prediction of anticoagulant response to warfarin.

Authors:  Qing-Xi Ooi; Daniel F B Wright; Geoffrey K Isbister; Stephen B Duffull
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.